UroGen Pharma Ltd. Analysis
| Analyst Ratings |
|
Average Target Price
|
28.40
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
4
|
|
# Buys
|
1
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.16
|
-1.13
|
0.03
|
2.59%
|
|
2022-06-30
|
-1.27
|
-1.18
|
0.09
|
7.09%
|
|
2022-03-31
|
-1.33
|
-1.25
|
0.08
|
6.02%
|
|
2021-12-31
|
-1.17
|
-1.27
|
-0.10
|
-8.55%
|
|
2021-09-30
|
-1.29
|
-1.35
|
-0.06
|
-4.65%
|
|
2021-06-30
|
-1.13
|
-1.17
|
-0.04
|
-3.54%
|
|
2021-03-31
|
-1.29
|
-1.17
|
0.12
|
9.30%
|
|
2020-12-31
|
-1.37
|
-1.38
|
-0.01
|
-0.73%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-3.56
|
|
2021-12-31
|
-4.96
|
|
2020-12-31
|
-5.92
|
|
2019-12-31
|
-5.11
|
|
2018-12-31
|
-4.76
|
|
2017-12-31
|
-2.57
|